Literature DB >> 25559799

Refining the Role for Adjuvant Radiotherapy in Gastric Cancer: Risk Stratification Is Key.

Karyn A Goodman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25559799     DOI： 10.1200/JCO.2014.59.1941

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance).

Authors:  Charles S Fuchs; Donna Niedzwiecki; Harvey J Mamon; Joel E Tepper; Xing Ye; Richard S Swanson; Peter C Enzinger; Daniel G Haller; Tomislav Dragovich; Steven R Alberts; Georg A Bjarnason; Christopher G Willett; Leonard L Gunderson; Richard M Goldberg; Alan P Venook; David Ilson; Eileen O'Reilly; Kristen Ciombor; David J Berg; Jeffrey Meyerhardt; Robert J Mayer
Journal:  J Clin Oncol       Date:  2017-10-04       Impact factor: 44.544

2.  Are the indications for postoperative radiotherapy in the NCCN guidelines for patients with gastric adenocarcinoma too broad? A study based on the SEER database.

Authors:  Ze-Ning Huang; Qi-Yue Chen; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Jun Lu; Long-Long Cao; Mi Lin; Ru-Hong Tu; Ju-Li Lin; Hua-Long Zheng; Chang-Ming Huang
Journal:  BMC Cancer       Date:  2018-11-03       Impact factor: 4.430

Review 3.  Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy.

Authors:  Ismael Riquelme; Kathleen Saavedra; Jaime A Espinoza; Helga Weber; Patricia García; Bruno Nervi; Marcelo Garrido; Alejandro H Corvalán; Juan Carlos Roa; Carolina Bizama
Journal:  Oncotarget       Date:  2015-09-22

4.  Development and Validation of a Nomogram to Predict the Benefit of Adjuvant Radiotherapy for Patients with Resected Gastric Cancer.

Authors:  Shu-Qiang Yuan; Wen-Jing Wu; Miao-Zhen Qiu; Zi-Xian Wang; Lu-Ping Yang; Ying Jin; Jing-Ping Yun; Yuan-Hong Gao; Yu-Hong Li; Zhi-Wei Zhou; Feng Wang; Rui-Hua Xu
Journal:  J Cancer       Date:  2017-09-29       Impact factor: 4.207
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.